CHINARES PHARMA

03320

4.3200.35% ( +0.015 )

Delay Trading: Oct 6, 15:55:31

Current ValuationThe current P/E ratio is 5.65, below the reasonable range, cheaper than 99.31% of the time in the past 5 years, and the industry ranks 3/52, the industry Median 6.62.

5.65xP/E

Stock priceHK$4.31Earnings per shareHK$0.76

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

Industry median 6.62x

010203040

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

Industry median 6.62x

0x20x40x60x80x100x

P/E ratio
Name/Symbol
03320HKCHINARES PHARMA	5.65x	7.23%	HK$27.05B
01513HKLIVZON PHARMA	9.97x	2.36%	HK$19.21B
01681HKCONSUN PHARMA	8.97x	20.93%	HK$12.14B
02186HKLUYE PHARMA	8.99x	46.95%	HK$7.21B
02877HKSHINEWAY PHARM	6.51x	16.75%	HK$6.03B
02633HKJACOBSON PHARMA	6.37x	1.99%	HK$1.92B
02348HKDAWNRAYS PHARMA	5.43x	--	HK$1.45B
02161HKJBM HEALTHCARE	6.62x	6.78%	HK$1.33B
08049HKJILIN CHANGLONG	5.17x	--	HK$1.30B
00239HKPAK FAH YEOW	7.68x	--	HK$760.40M
00950HKLEE'S PHARM	5.68x	--	HK$680.10M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.